Skip to main content
. 2022 Oct 8;15:143. doi: 10.1186/s13045-022-01362-9

Fig. 1.

Fig. 1

Statistics of FDA-approved drugs and cancer drugs. a Number of FDA-approved drugs (NMEs: New molecular entities, BLAs: Biologics license applications) over the past 31 years. b Number of FDA-approved cancer drugs over the past 31 years. c Number of FDA-approved therapeutic drugs for solid tumors during the past 31 years